Christopher J Scott

Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells.

Maelíosa T. C. McCrudden, Bernard Malissen, Ryan F Donnelly, 2015, The Journal of investigative dermatology.

Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles.

Brendan F Gilmore, P. McCarron, F. Fay, 2010, Biomaterials.

Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers.

Desmond I. J. Morrow, Ryan F Donnelly, F. Fay, 2010, Photodiagnosis and photodynamic therapy.

Cathepsin S: therapeutic, diagnostic, and prognostic potential

C. Scott, R. Burden, Christopher J Scott, 2015, Biological chemistry.

Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy.

C. Scott, Christopher J Scott, Michael C Johnston, 2018, Drug discovery today. Technologies.

Forming next-generation antibody–nanoparticle conjugates through the oriented installation of non-engineered antibody fragments† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc02747h

Katrina Campbell, Vijay Chudasama, Peter Smyth, 2017, Chemical science.

Antibody-targeted nanoparticles for cancer therapy.

F. Fay, C. Scott, Francois Fay, 2011, Immunotherapy.